DARA WRIGHT - 01 Sep 2023 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
Executive Vice President
Signature
/s/ Dara Wright
Issuer symbol
BIO
Transactions as of
01 Sep 2023
Net transactions value
-$185,857
Form type
4
Filing time
06 Sep 2023, 13:08:49 UTC
Previous filing
19 Dec 2022
Next filing
12 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +520 +29% $0.000000 2,315 01 Sep 2023 Direct F1, F2
transaction BIO Bio-Rad A Common Stock Tax liability $71,028 -180 -7.8% $394.60 2,135 01 Sep 2023 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +405 +19% $0.000000 2,540 01 Sep 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability $55,639 -141 -5.6% $394.60 2,399 01 Sep 2023 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +433 +18% $0.000000 2,832 02 Sep 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability $59,190 -150 -5.3% $394.60 2,682 02 Sep 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Award $0 +3,005 $0.000000 3,005 01 Sep 2023 Bio-Rad A Common Stock 3,005 $0.000000 Direct F3, F4
transaction BIO Restricted Stock Units Options Exercise $0 -520 -25% $0.000000 1,562 01 Sep 2023 Bio-Rad A Common Stock 520 $0.000000 Direct F3, F5
transaction BIO Restricted Stock Units Options Exercise $0 -405 -33% $0.000000 811 01 Sep 2023 Bio-Rad A Common Stock 405 $0.000000 Direct F3, F6
transaction BIO Restricted Stock Units Options Exercise $0 -433 -50% $0.000000 434 02 Sep 2023 Bio-Rad A Common Stock 433 $0.000000 Direct F3, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Includes 14.0360 and 18.9240 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2023 and 06/30/2023.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4 The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F5 On September 1, 2022, the reporting person was granted 2,082 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F6 On September 1, 2021, the reporting person was granted 1,621 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F7 On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.